173 related articles for article (PubMed ID: 33438475)
21. Chronic hepatitis caused by persistent parvovirus B19 infection.
Mogensen TH; Jensen JM; Hamilton-Dutoit S; Larsen CS
BMC Infect Dis; 2010 Aug; 10():246. PubMed ID: 20727151
[TBL] [Abstract][Full Text] [Related]
22. [Fetal Parvowirus B19 infection with hydrops fetalis, a case report].
Engel K; Grabarczyk P; Celewicz Z; Grzymała-Figura A; Wegrzynowski J; Brojer E
Ginekol Pol; 2012 Feb; 83(2):141-4. PubMed ID: 22568361
[TBL] [Abstract][Full Text] [Related]
23. Quantitation of human parvovirus B19 DNA in erythema infectiosum and aplastic crisis.
Ishikawa A; Yoto Y; Tsugawa T; Tsutsumi H
J Med Virol; 2014 Dec; 86(12):2102-6. PubMed ID: 24962467
[TBL] [Abstract][Full Text] [Related]
24. Genotyping of Human parvovirus B19 among Brazilian patients with hemoglobinopathies.
Slavov SN; Kashima S; Silva-Pinto AC; Covas DT
Can J Microbiol; 2012 Feb; 58(2):200-5. PubMed ID: 22280886
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
26. Erythema infectiosum and other parvovirus B19 infections.
Kirchner JT
Am Fam Physician; 1994 Aug; 50(2):335-41. PubMed ID: 8042568
[TBL] [Abstract][Full Text] [Related]
27. A study by means of a new assay of the relationship between an outbreak of erythema infectiosum and non-immune hydrops fetalis caused by human parvovirus B19.
Yaegashi N; Okamura K; Tsunoda A; Nakamura M; Sugamura K; Yajima A
J Infect; 1995 Nov; 31(3):195-200. PubMed ID: 8586838
[TBL] [Abstract][Full Text] [Related]
28. Parvovirus B19 infection in pregnancy.
Eis-Hübinger AM; Dieck D; Schild R; Hansmann M; Schneweis KE
Intervirology; 1998; 41(4-5):178-84. PubMed ID: 10213893
[TBL] [Abstract][Full Text] [Related]
29. Serologic study of human parvovirus B19 infection in pregnancy in Japan.
Yaegashi N; Niinuma T; Chisaka H; Uehara S; Okamura K; Shinkawa O; Tsunoda A; Moffatt S; Sugamura K; Yajima A
J Infect; 1999 Jan; 38(1):30-5. PubMed ID: 10090504
[TBL] [Abstract][Full Text] [Related]
30. Human parvovirus B19 infection.
Carper E; Kurtzman GJ
Curr Opin Hematol; 1996 Mar; 3(2):111-7. PubMed ID: 9372060
[TBL] [Abstract][Full Text] [Related]
31. Quantitative analysis of human parvovirus B19 DNA in maternal and fetal serum, and amniotic fluid during an early stage of pregnancy.
Ishikawa A; Yoto Y; Asakura H; Tsutsumi H
J Med Virol; 2015 Apr; 87(4):683-5. PubMed ID: 25611946
[TBL] [Abstract][Full Text] [Related]
32. [Human parvovirus B19 (HPV-B19), a clinical overview with emphasis of rheumatologic manifestations].
Jelk W; Tyndall A
Z Rheumatol; 1994; 53(2):59-65. PubMed ID: 8023586
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.
Grabarczyk P; Kalińska A; Kara M; Wieczorek R; Ejduk A; Sulkowska E; Gołębiowska-Staroszczyk S; Matysiak M; Baylis SA; Brojer E
J Med Virol; 2011 Jan; 83(1):142-9. PubMed ID: 21108352
[TBL] [Abstract][Full Text] [Related]
34. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
[TBL] [Abstract][Full Text] [Related]
35. Clinical impact & pathogenic mechanisms of human parvovirus B19: A multiorgan disease inflictor incognito.
Kishore J; Kishore D
Indian J Med Res; 2018 Oct; 148(4):373-384. PubMed ID: 30666000
[TBL] [Abstract][Full Text] [Related]
36. [Parvovirus B19: importance of diathesis in the clinical expression of a common infection].
Germanaud D; Sermet-Gaudelus I
Rev Prat; 2007 May; 57(10):1049-55. PubMed ID: 17844796
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.
Hemauer A; Gigler A; Searle K; Beckenlehner K; Raab U; Broliden K; Wolf H; Enders G; Modrow S
J Med Virol; 2000 Jan; 60(1):48-55. PubMed ID: 10568763
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of parvovirus B19 infection in patients with chronic kidney disease under hemodialysis: A multicenter study.
Alves ADR; Langella BB; Barbosa JR; Lima DM; Colares JKB; Garcia RCNC; Pinto MA; Villar LM; Amado LA
Int J Infect Dis; 2020 Nov; 100():350-356. PubMed ID: 32927082
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.
Abdelrahman D; Al-Sadeq DW; Smatti MK; Taleb SA; AbuOdeh RO; Al-Absi ES; Al-Thani AA; Coyle PV; Al-Dewik N; Qahtani AAA; Yassine HM; Nasrallah GK
Viruses; 2021 Mar; 13(4):. PubMed ID: 33805034
[TBL] [Abstract][Full Text] [Related]
40. [Molecular epidemiology of parvovirus infection in Belarus].
Ermoloich MA; Semeĭko GV; Samoĭlovich EO; Hubschen JM; Muller CP
Vopr Virusol; 2010; 55(2):26-31. PubMed ID: 20455468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
